Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5088769
Max Phase: Preclinical
Molecular Formula: C30H42N4O8S
Molecular Weight: 618.75
Molecule Type: Unknown
Associated Items:
ID: ALA5088769
Max Phase: Preclinical
Molecular Formula: C30H42N4O8S
Molecular Weight: 618.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c2c(c(C(=O)Nc3cc(S(=O)(=O)N4CCOCC4)ccc3OCCCCCCCC(=O)NO)n1C)CCCCC2=O
Standard InChI: InChI=1S/C30H42N4O8S/c1-21-28-23(10-7-8-11-25(28)35)29(33(21)2)30(37)31-24-20-22(43(39,40)34-15-18-41-19-16-34)13-14-26(24)42-17-9-5-3-4-6-12-27(36)32-38/h13-14,20,38H,3-12,15-19H2,1-2H3,(H,31,37)(H,32,36)
Standard InChI Key: LYHODAWVJTVENH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 618.75 | Molecular Weight (Monoisotopic): 618.2723 | AlogP: 3.74 | #Rotatable Bonds: 13 |
Polar Surface Area: 156.27 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.91 | CX Basic pKa: | CX LogP: 2.89 | CX LogD: 2.88 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.13 | Np Likeness Score: -1.15 |
1. Schäker-Hübner L, Warstat R, Ahlert H, Mishra P, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Breit B, Bhatia S, Hügle M, Günther S, Hansen FK.. (2021) 4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads., 64 (19.0): [PMID:34582215] [10.1021/acs.jmedchem.1c01119] |
Source(1):